Sick Kids Need Faster Drug Testing

January 25, 2014

Dana-Farber Boston Children's Buildings

Whether guided by economics or an instinct to shield children from potential harm, the way we bring new pediatric drugs to market does not always serve the best interests of children with life-threatening illness for whom few options exist, Stephen E. Sallan, MD, writes in The Boston Globe. As a pediatric oncologist for 40 years, Sallan notes he has witnessed a revolution in cancer treatment, launched by early advances in treating children that later also benefited adults. Today, however, children with intractable disease are too often left behind and denied timely access to breakthroughs in cancer treatment that could save their lives.

Read the full story.

Media Inquiries

Irene Sege
Senior Media Relations Specialist

Follow Us!

Stay updated on our latest news and developments by following us on Twitter.

Twitter Logo